- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Maze Therapeutics Inc (MAZE)
Assess today's live Maze Therapeutics Inc (MAZE) share price, performance and insights using our live NASDAQ: MAZE stock exchange data.
Analyse the historical data and Maze Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Maze Therapeutics share price buy/sell indicators using real-time data (or discuss the Maze Therapeutics (MAZE) stock price today with other investors in the Maze Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MAZE share price (ISIN: US5787841007) to enhance your trading decisions with our free investment tools and resources.
What Is the Maze Therapeutics Inc Share Price Today?
The Maze Therapeutics share price today is 42.30.
What Is the Stock Symbol for Maze Therapeutics Inc
The stock symbol (or 'ticker') for Maze Therapeutics Inc is "MAZE."
What Stock Exchange Does Maze Therapeutics Inc Trade On?
Maze Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Maze Therapeutics Inc a Good Stock to Buy?
Determining whether Maze Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Maze Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Maze Therapeutics share price buy/sell indicators using real-time data (or discuss the Maze Therapeutics (MAZE) stock price today with other investors in the Maze Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ MAZE share price (ISIN: US5787841007) to enhance your trading decisions with our free investment tools and resources.
What Is the Maze Therapeutics Inc Share Price Today?
The Maze Therapeutics share price today is 42.30.
What Is the Stock Symbol for Maze Therapeutics Inc
The stock symbol (or 'ticker') for Maze Therapeutics Inc is "MAZE."
What Stock Exchange Does Maze Therapeutics Inc Trade On?
Maze Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Maze Therapeutics Inc a Good Stock to Buy?
Determining whether Maze Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.37
43.17
52 wk Range
6.71
43.29
MAZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.3743.17
52 wk Range
6.7143.29
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MAZE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
46.56
Upside
+10.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Maze Therapeutics Company Profile
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. The company also offers MZE001, a clinical program for the treatment of Pompe disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Compare MAZE to Peers and Sector
Metrics to compare | MAZE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMAZEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.1x | −0.7x | −0.6x | |
PEG Ratio | −0.35 | 0.01 | 0.00 | |
Price/Book | 5.4x | 2.1x | 2.6x | |
Price / LTM Sales | - | 1.4x | 3.2x | |
Upside (Analyst Target) | 14.3% | 420.4% | 41.8% | |
Fair Value Upside | Unlock | 39.0% | 5.1% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 46.56
(+10.06% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.66 / -0.62
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Maze Therapeutics (MAZE) Share Price Today?
The live Maze Therapeutics share price today is 42.30
What Stock Exchange Does Maze Therapeutics (MAZE) Trade On?
Maze Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Maze Therapeutics?
The stock symbol (also called a 'ticker') for Maze Therapeutics is "MAZE."
What Is the Current Maze Therapeutics Market Cap?
As of today, Maze Therapeutics market capitalisation is 2.04B.
What Is Maze Therapeutics's (MAZE) Earnings Per Share (TTM)?
The Maze Therapeutics EPS is currently -3.39 (Trailing Twelve Months).
When Is the Next Maze Therapeutics Earnings Date?
Maze Therapeutics's next earnings report will be released on 03 Dec 2025.
Is MAZE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Maze Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Maze Therapeutics Stock Split?
Maze Therapeutics has split 0 times. (See the MAZE stock split history page for full effective split date and price information.)
How Many Employees Does Maze Therapeutics Have?
Maze Therapeutics has 125 employees.
What is the current trading status of Maze Therapeutics (MAZE)?
As of 24 Dec 2025, Maze Therapeutics (MAZE) is trading at a price of 42.30, with a previous close of 41.98. The stock has fluctuated within a day range of 41.37 to 43.17, while its 52-week range spans from 6.71 to 43.29.
What Is Maze Therapeutics (MAZE) Price Target According to Analysts?
The average 12-month price target for Maze Therapeutics is USD46.55556, with a high estimate of USD60 and a low estimate of USD34. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +10.06% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.